dna insulin drops · Liquid

What changed in the last 90 days

Every detected change for dna insulin drops, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Insulin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• attention deficit mild drops· 1 maker
• attention deficit severe drops· 1 maker
• insulin aspart injection· 1 maker
• insulin aspart-fsan· 1 maker
• insulin aspart-xjhz· 1 maker
• insulin degludec and liraglutide· 1 maker
• insulin glargine and lixisenatide· 1 maker
• insulin glargine-aldy· 1 maker
• insulin glulisine· 1 maker
• pancreas db liquescence· 1 maker
• insulin· 2 makers
• insulin aspart-szjj· 2 makers

Common questions

Is Dna insulin drops in shortage right now?

No. FDA does not currently list Dna insulin drops in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Dna insulin drops?

1 company has marketed Dna insulin drops in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.